SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934
Privia Health Group, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware | 85-3599420 | |
(State of Incorporation or Organization) | (I.R.S. Employer Identification No.) | |
950 N. Glebe Road Suite 700 Arlington, Virginia |
22203 | |
(Address of Principal Executive Offices) | (Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class |
Name of Each Exchange on Which | |
Common Stock, par value $0.01 per share | The Nasdaq Global Select Market |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. ☒:
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ☐
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement file number to which this form relates:
333-255086
(If applicable)
Securities to be registered pursuant to Section 12(g) of the Act:
(Title of Class)
N/A
Item 1: | Description of Registrants Securities to be Registered |
The description under the heading Description of Capital Stock relating to the Registrants common stock, par value $0.01 per share (the Common Stock), in the prospectus included in the Registrants Registration Statement on Form S-1 (Registration No. 333-255086) originally filed with the Securities and Exchange Commission on April 7, 2021, as amended (the Registration Statement), is incorporated by reference herein. In addition, the description that will be included under the heading Description of Capital Stock relating to the Common Stock in the Registrants final prospectus relating to the Registration Statement to be subsequently filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be incorporated by reference herein.
Item 2: | Exhibits |
Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Global Select Market and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
Privia Health Group, Inc. | ||||
By: | /s/ Thomas Bartrum | |||
Name: | Thomas Bartrum | |||
Title: | Chief Executive Officer |
Date: April 26, 2021